Hans-Juergen Salwender

Midostaurin in Combination with Intensive Induction and As Single Agent Maintenance Therapy after Consolidation Therapy with Allogeneic Hematopoietic Stem Cell Transplantation or High-Dose Cytarabine (NCT01477606)

Richard F. Schlenk, Konstanze Döhner, Helmut R. Salih et al. · Blood · 2015 · 43 citations

Medicine, Hematology, Pharmacotherapy +12

Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial

Pieter Sonneveld, Hans-Juergen Salwender, Bronno van der Holt et al. · Blood · 2015 · 38 citations

Medicine, Hematology, Pharmacotherapy +17

Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial

Richard F. Schlenk, Walter Fiedler, Helmut R. Salih et al. · Blood · 2016 · 22 citations

Medicine, Hematology, Oncology +8

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Isabel Sánchez‐Ortega, Grzegorz Basak, Eric Beohou et al. · Blood · 2016 · 12 citations

Medicine, Geriatric Medicine, Hematology +14